Works by Guo, Yang


Results: 2617
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    A phase 1, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of KN056 (a recombinant human GLP-1 variant Fc fusion protein) in healthy Chinese participants.

    Published in:
    Expert Opinion on Investigational Drugs, 2025, v. 34, n. 4, p. 329, doi. 10.1080/13543784.2025.2500303
    By:
    • Qin, Yuan-Fang;
    • Zhang, Wen-Hua;
    • Zhang, Hao-Nan;
    • Li, Yu-Wei;
    • Huang, Wen-Qiao;
    • Xie, Jin-Lian;
    • Yang, Shuang;
    • Li, Lan-Ni;
    • Cui, Chang;
    • Pei, Qi;
    • Huang, Jie;
    • Yang, Guo-Ping
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50